JP2022538286A5 - - Google Patents
Info
- Publication number
- JP2022538286A5 JP2022538286A5 JP2021577316A JP2021577316A JP2022538286A5 JP 2022538286 A5 JP2022538286 A5 JP 2022538286A5 JP 2021577316 A JP2021577316 A JP 2021577316A JP 2021577316 A JP2021577316 A JP 2021577316A JP 2022538286 A5 JP2022538286 A5 JP 2022538286A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic composition
- composition according
- compound
- acid
- lmtx
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1909506.6 | 2019-07-02 | ||
| GBGB1909506.6A GB201909506D0 (en) | 2019-07-02 | 2019-07-02 | Synaptopathies |
| PCT/EP2020/068306 WO2021001326A1 (en) | 2019-07-02 | 2020-06-29 | Methylthioninium for use in the treatment of synaptopathies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022538286A JP2022538286A (ja) | 2022-09-01 |
| JP2022538286A5 true JP2022538286A5 (enExample) | 2023-07-07 |
| JP7610537B2 JP7610537B2 (ja) | 2025-01-08 |
Family
ID=67540130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021577316A Active JP7610537B2 (ja) | 2019-07-02 | 2020-06-29 | シナプス変性症の処置における使用のためのメチルチオニニウム |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220370470A1 (enExample) |
| EP (1) | EP3993805A1 (enExample) |
| JP (1) | JP7610537B2 (enExample) |
| KR (1) | KR20220029711A (enExample) |
| CN (1) | CN114080224A (enExample) |
| AU (1) | AU2020300792B2 (enExample) |
| BR (1) | BR112021025383A2 (enExample) |
| CA (1) | CA3143787A1 (enExample) |
| GB (1) | GB201909506D0 (enExample) |
| IL (1) | IL289371A (enExample) |
| MX (1) | MX2021015288A (enExample) |
| WO (1) | WO2021001326A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY148145A (en) | 2006-07-11 | 2013-03-15 | Wista Lab Ltd | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| FI4385512T3 (fi) | 2018-07-26 | 2026-01-12 | Taurx Therapeutics Man Ltd | Diaminofenotiatsiinien optimoitu annostus populaatioille |
| WO2021211640A1 (en) * | 2020-04-14 | 2021-10-21 | University Of Florida Research Foundation, Incorporated | Enhanced effects of gene-immunotherapy and immunosuppressants in multiple sclerosis |
| US12410394B2 (en) | 2023-01-06 | 2025-09-09 | Athergen, Inc. | Composition comprising nicotinamide mononucleotide and leucomethylene blue |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020040032A1 (en) | 2000-07-07 | 2002-04-04 | Glasky Michelle S. | Methods for stimulation of synthesis of synaptophysin in the central nervous system |
| GB0100119D0 (en) | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| ES2349322T7 (es) | 2006-03-29 | 2019-10-17 | Wista Lab Ltd | Sales de 3,7-diamino-10H-fenotiazina y su utilización |
| AU2008265045B2 (en) | 2007-06-19 | 2014-02-27 | Taurx Therapeutics Management Ltd. | Phenothiazine compounds for treating Mild Cognitive Impairment |
| CA2701075C (en) | 2007-10-03 | 2019-02-12 | Wista Laboratories Ltd. | Therapeutic use of diaminophenothiazines. |
| JP5898701B2 (ja) | 2011-02-11 | 2016-04-13 | ウィスタ ラボラトリーズ リミテッド | フェノチアジンジアミニウム塩およびそれらの使用 |
| JP7073330B2 (ja) * | 2016-07-25 | 2022-05-23 | ウィスタ ラボラトリーズ リミテッド | ジアミノフェノチアジンの投与及び投与量 |
| GB201614834D0 (en) | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
| JP6756661B2 (ja) | 2017-04-28 | 2020-09-16 | 日立オートモティブシステムズ株式会社 | 車両電子制御装置 |
-
2019
- 2019-07-02 GB GBGB1909506.6A patent/GB201909506D0/en not_active Ceased
-
2020
- 2020-06-29 MX MX2021015288A patent/MX2021015288A/es unknown
- 2020-06-29 CN CN202080048560.8A patent/CN114080224A/zh active Pending
- 2020-06-29 CA CA3143787A patent/CA3143787A1/en active Pending
- 2020-06-29 BR BR112021025383A patent/BR112021025383A2/pt unknown
- 2020-06-29 EP EP20737381.2A patent/EP3993805A1/en active Pending
- 2020-06-29 KR KR1020227003215A patent/KR20220029711A/ko not_active Ceased
- 2020-06-29 AU AU2020300792A patent/AU2020300792B2/en active Active
- 2020-06-29 JP JP2021577316A patent/JP7610537B2/ja active Active
- 2020-06-29 US US17/620,966 patent/US20220370470A1/en not_active Abandoned
- 2020-06-29 WO PCT/EP2020/068306 patent/WO2021001326A1/en not_active Ceased
-
2021
- 2021-12-26 IL IL289371A patent/IL289371A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022538286A5 (enExample) | ||
| EP2323696B1 (en) | Optical method for the detection of alzheimer's disease | |
| JP2015510941A5 (enExample) | ||
| JP2018035197A5 (enExample) | ||
| JP2024516371A5 (enExample) | ||
| JP2022515293A5 (enExample) | ||
| JP2019532029A5 (enExample) | ||
| JP2009510044A5 (enExample) | ||
| Prasetyo | The primary, secondary, and tertiary brain injury | |
| JP2015508092A5 (enExample) | ||
| JP2019529541A5 (enExample) | ||
| JP2018534286A5 (enExample) | ||
| JP2020504156A5 (enExample) | ||
| JP2009501202A5 (enExample) | ||
| JP2019529514A5 (enExample) | ||
| JP2013544786A5 (enExample) | ||
| JP2019515040A5 (enExample) | ||
| JP2024531437A5 (enExample) | ||
| JP2018509426A5 (enExample) | ||
| US20160193143A1 (en) | Medicinal treatment of dermal infectious disorders with norketotifen | |
| JP2022524111A5 (enExample) | ||
| JP2022552520A5 (enExample) | ||
| JP2009526834A5 (enExample) | ||
| CA2886194C (en) | Medicinal treatment of chronic dermal inflammatory diseases with norketotifen | |
| JP2022512373A5 (enExample) |